semaglutide a1c reduction FDA-Approved Oral Semaglutide: The First GLP-1 Pill High Dose Ozempic Superior at

Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study

If you look across the randomized trials, the adverse event rates to me are fairly alarming

judging it at day 3 tells you nothing

Reported preclinical rodent studies have employed diet-induced-obese and GLP-1R knockout mouse models together with indirect calorimetry and pair-feeding designs as experimental tools to examine how the three receptor pathways contribute to measured signaling readouts, and cell and tissue systems have been used to probe hepatic lipid handling at the biochemical level

These are starting points